Exemplis Discimus 2005, 149(1):89-91

Donec nec eros id tortor scelerisque rutrum.

Cally Samicka, Darin Sunfellb, Reima Lurechiaa, Eiko Ardenc, Kerrick Zorabosd
a National Institute of Nuclear Medicine, Dalonbian Teaching Hospital, Mustafar Republic
b 2nd Clinic of Parasitology, Gricho University Hospital, Boz Pity Republic
c Faculty of Infectious diseases, University of Geonosis, Republic of Kashyyyk
d Centre of Cardiology, Mayagil Faculty Hospital, Polis Massa Republic

Donec orci leo, pellentesque non, hendrerit vestibulum, tempor eu, libero.. Praesent odio neque, congue in, iaculis vitae, eleifend in, pede. Proin velit sem, volutpat ac, interdum vel, vulputate non, lacus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Praesent magna lorem, adipiscing non, tristique ut, condimentum et, lorem. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Curabitur elit urna, interdum nec, sagittis aliquam, vestibulum eget, augue.. Proin justo lacus, suscipit at, imperdiet a, sollicitudin vel, tellus.

Keywords: Fusce odio, Etiam in nulla, Ut tristique, Duis ac tellus

Received: April 7, 2005; Accepted: June 3, 2005; Published: July 1, 2005 

Open full article

References

  1. Hansen MS, Stanton EB, Gawad Y. (2002) Relation of Circulationg Cardiac Myosin Light Chain 1 Isoform in Stable Severe Congestive Heart Failure to Survival and Treatment With Flosequinan. Am Journal of Cardiology 90, 969-973. Go to original source... Go to PubMed...
  2. Hillis GS, Zhao N, Dalsey WC. (1999) Utility of cardiac troponin I, creatine kinase-MB mass, myosin light chain 1, and myoglobin in the early in-hospital triage of high risk patients with chest pain. Heart 82, 614-320. Go to original source... Go to PubMed...
  3. Sawada H, Nagata I, Shoraki K. (2003) Serum Concentration of MLC-1 and Left ventricular Shortening Fraction of Neonates. Yonago Acta Medica 42, 69-78.
  4. Goto T, Takase H, Tariyama T. (2003) Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 89, 1303-1307. Go to original source... Go to PubMed...
  5. Communal C, Sumandea M, Tombe P. (2002) Functional consequenses of caspase activation in cardiac myocytes. PNAS 99, 6252-6256. Go to original source... Go to PubMed...
  6. ©pinar J, Vítovec K. (1992) Radiologic Changes in chronic heart failure. Cor et Vasa 34, 88-99. Go to PubMed...
  7. Nageh T, Chin D, Cooke JC, Meehan A, Monaghan MJ, Sherwood RA. (2002) Interpretation of plasma brain natriuretic peptide concentrations may require adjustment for patients age. Ann Clin Biochem 39, 151-153. Go to original source... Go to PubMed...
  8. Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H. (2002) Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89, 691-695. Go to original source... Go to PubMed...
  9. Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS. (2002) Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 105, 595-596. Go to original source... Go to PubMed...
  10. Harrison A, Morrison LK, Krishnaswamy P, Kazanegra R, Clopton P, Dao Q, Hlavin P, Maisel AS. (2002) B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. Emerg Med 39, 131-138. Go to original source... Go to PubMed...

Return to the content